Opko Historical Cash Flow
| OPK Stock | USD 1.58 0.03 1.94% |
Analysis of Opko Health cash flow over time is an excellent tool to project Opko Health future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 26.9 M or Capital Expenditures of 9.4 M as it is a great indicator of Opko Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Opko Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Opko Health is a good buy for the upcoming year.
Opko |
About Opko Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Opko balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Opko's non-liquid assets can be easily converted into cash.
Opko Health Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Opko Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Opko Health current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.At this time, Opko Health's Total Cashflows From Investing Activities is quite stable compared to the past year. Change To Account Receivables is expected to rise to about 3.6 M this year, although the value of Other Cashflows From Financing Activities is projected to rise to (258.4 K).
Opko Health cash flow statement Correlations
Click cells to compare fundamentals
Opko Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Opko Health cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (11.0M) | (13.2M) | 62.5M | 18.5M | (57.3M) | (54.4M) | |
| Free Cash Flow | (185.3M) | 5.8M | 6.2M | (119.8M) | (44.5M) | (42.2M) | |
| Change In Working Capital | (68.8M) | (97.6M) | (20.5M) | 42.7M | 21.8M | 22.9M | |
| Begin Period Cash Flow | 96.5M | 85.5M | 72.2M | 134.7M | 153.2M | 160.9M | |
| Other Cashflows From Financing Activities | 487.3M | 756K | 1.1M | (774K) | (272K) | (258.4K) | |
| Depreciation | 93.8M | 85.4M | 78.7M | 108.7M | 105.3M | 110.6M | |
| Other Non Cash Items | 99.7M | (3.5M) | (13.5M) | 137.8M | 22.0M | 26.9M | |
| Capital Expenditures | 12.7M | 33.7M | 32.2M | 24.6M | 16.3M | 9.4M | |
| Total Cash From Operating Activities | (172.5M) | 39.5M | 38.3M | (95.2M) | (28.2M) | (29.6M) | |
| Net Income | (314.9M) | 30.6M | (30.1M) | (328.4M) | (188.9M) | (179.4M) | |
| Total Cash From Financing Activities | 175.2M | (35.1M) | (10.4M) | 23.0M | (11.3M) | (10.7M) | |
| End Period Cash Flow | 85.5M | 72.2M | 134.7M | 153.2M | 95.9M | 63.7M | |
| Sale Purchase Of Stock | 2.1M | 93.7M | (3K) | (272K) | (312.8K) | (297.2K) | |
| Change To Netincome | 11.0M | 104.8M | 19.9M | 9.3M | 10.7M | 10.2M | |
| Change To Liabilities | (10.0M) | (24.4M) | 16.4M | 119.0M | (44.6M) | 0.0 | |
| Total Cashflows From Investing Activities | (26.1M) | (13.3M) | (18.3M) | 35.9M | 32.4M | 34.0M | |
| Change To Account Receivables | 7.4M | (150.4M) | 5.2M | 128.6M | 3.4M | 3.6M | |
| Stock Based Compensation | 13.4M | 8.9M | 13.6M | 18.5M | 11.4M | 15.1M | |
| Change To Inventory | (12.1M) | (77.6M) | 30.7M | 13.7M | 15.2M | 16.0M | |
| Investments | (1.2M) | 15.1M | 6.1M | 91.0M | (24.7M) | (23.4M) | |
| Change Receivables | 20.4M | 7.4M | (150.4M) | 5.2M | 4.7M | 4.9M | |
| Net Borrowings | 47.2M | 99.2M | (35.8M) | (11.4M) | (10.3M) | (9.8M) | |
| Cash And Cash Equivalents Changes | 5.0M | (10.5M) | (13.9M) | 63.9M | 57.5M | 60.4M | |
| Cash Flows Other Operating | (65.3M) | (68.8M) | 11.9M | (11.7M) | (10.5M) | (11.0M) | |
| Other Cashflows From Investing Activities | 1.2M | 671K | 245K | 62.0M | 55.8M | 58.6M | |
| Change To Operating Activities | 4.2M | (10.4M) | 98.7M | (29.6M) | (26.7M) | (25.3M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share 0.998 | Quarterly Revenue Growth (0.03) | Return On Assets (0.09) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.